| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
alpha1 Antitrypsin and its deficiency A1ATVasculitis (BASKET)CefoperazonePulmonary emphysemaLung (CT)| 1 | 1984 | alpha 1-Antitrypsin deficiency. | 
| + | - | nl | South Med J 77(4):479-83 (1984) |
| 2 | 1996 | Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency. | 
| + | - | nl | QJM 89(8):599-611 (1996) |
| 3 | 2010 | Intravenous alpha-1 antitrypsin augmentation therapy: systematic review. | 
| + | - | nl | Dan Med Bull 57(9):A4175 (2010) Gotzsche PC |
| 4 | 2007 | Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. | 
| + | - | nl | Neth J Med 65(5):160-6 (2007) Kok KF |
| 5 | 2007 | Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. | 
| + | - | nl | Cleve Clin J Med 74(12):869-74 (2007) Stoller JK |
| 6 | 2009 | Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. | 
| + | - | nl | Biologics 3():193-204 (2009) Petrache I |
| 7 | 1999 | Cefoperazone prevents the inactivation of alpha(1)-antitrypsin by activated neutrophils. | 
| + | - | nl | Antimicrob Agents Chemother 43(9):2307-10 (1999) |
| 8 | 2006 | Alpha1-antitrypsin deficiency: current perspective on research, diagnosis, and management. | 
| + | - | nl | Int J Chron Obstruct Pulmon Dis 1(2):151-60 (2006) Stolk J |
| 9 | 1999 | Alpha 1-antitrypsin deficiency and related liver disease. | 
| + | - | nl | Saudi J Gastroenterol 5(1):1-8 (1999) |
| 10 | 2003 | American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. | 
| + | - | nl | Am J Respir Crit Care Med 168(7):818-900 (2003) |
| 11 | 1976 | Alpha 1-antitrypsin deficiency and infantile liver disease. | 
| + | - | nl | Arch Dis Child 51(8):584-8 (1976) |
| 12 | 2006 | The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins. | 
| + | - | nl | Autophagy 2(4):258-63 (2006) Perlmutter DH |
| 13 | 2009 | Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency. | 
| + | - | nl | Cell Death Differ 16(1):39-45 (2009) Perlmutter DH |
| 14 | 2005 | Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry. | 
| + | - | nl | Chest 127(4):1196-204 (2005) Stoller JK |
| 15 | 2004 | Alpha1-antitrypsin deficiency: more than a protease imbalance? | 
| + | - | nl | Chest 125(5):1607-9 (2004) Wewers MD |
| 16 | 2003 | Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. | 
| + | - | nl | Chest 123(5):1425-34 (2003) Stoller JK |
| 17 | 1996 | Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency. | 
| + | - | nl | Chest 110(6 Suppl):251S-255S (1996) |
| 18 | 1996 | Alpha 1-antitrypsin deficiency. A conformational disease. | 
| + | - | nl | Chest 110(6 Suppl):243S-247S (1996) |
| 19 | 1996 | A 30-year perspective on alpha 1-antitrypsin deficiency. | 
| + | - | nl | Chest 110(6 Suppl):237S-242S (1996) |
| 20 | 2004 | Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies. | 
| + | - | nl | Eur J Hum Genet 12(3):167-72 (2004) Crowther DC |
| 21 | 2007 | Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise? | 
| + | - | nl | Eur Respir J 29(2):229-30 (2007) Brennan S |
| 22 | 2005 | alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants. | 
| + | - | nl | Eur Respir J 26(5):909-17 (2005) Senn O |
| 23 | 1990 | Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. | 
| + | - | nl | J Clin Invest 85(5):1343-52 (1990) |
| 24 | 1986 | alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. | 
| + | - | nl | J Clin Invest 78(6):1427-31 (1986) |
| 25 | 2008 | Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. | 
| + | - | nl | Orphanet J Rare Dis 3():16 (2008) Fregonese L |
| 26 | 2008 | Alpha-1 antitrypsin: now available, but do we need it? | 
| + | - | nl | Swiss Med Wkly 138(13-14):191-6 (2008) Russi EW |
| 27 | 2004 | Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency. | 
| + | - | nl | Thorax 59(11):986-91 (2004) Shaker SB |
| 28 | 2004 | alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency. | 
| + | - | nl | Thorax 59(10):904-9 (2004) Sandhaus RA |
| 29 | 2004 | alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding. | 
| + | - | nl | Thorax 59(8):708-12 (2004) Stoller JK |
| 30 | 2004 | Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. | 
| + | - | nl | Thorax 59(6):529-35 (2004) Lomas DA |
| 31 | 2004 | Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. | 
| + | - | nl | Thorax 59(5):441-5 (2004) Needham M |
| 32 | 2004 | Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. | 
| + | - | nl | Thorax 59(3):259-64 (2004) DeMeo DL |
| 33 | 1987 | Association of alpha 1-antitrypsin deficiency with lung and liver diseases. | 
| + | - | nl | West J Med 147(1):48-53 (1987) |
| 34 | 2007 | Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review. | 
| + | - | nl | Hepatology 45(5):1313-23 (2007) Perlmutter DH |
| 35 | 1996 | Molecular pathogenesis of liver disease in alpha1-antitrypsin deficiency. | 
| + | - | nl | Hepatology 24(6):1504-16 (1996) |
| 36 | 2003 | Key current clinical issues in alpha-1 antitrypsin deficiency. | 
| + | - | nl | Respir Care 48(12):1216-21; discussion 1221-4 (2003) |
| 37 | 2003 | Alpha-1 antitrypsin deficiency: an under-recognized but important issue for respiratory therapists. | 
| + | - | nl | Respir Care 48(11):1022-4 (2003) |
| 38 | 2009 | Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. | 
| + | - | nl | Chest 135(3):600-8 (2009) |
| 39 | 2009 | Alpha1-antitrypsin deficiency: lessons from longevity. | 
| + | - | nl | Chest 135(3):591-2 (2009) Eden E |
| 40 | 2008 | Screening and familial testing of patients for alpha 1-antitrypsin deficiency. | 
| + | - | nl | Chest 133(4):981-8 (2008) |
| 41 | 2010 | Intracellular processing of alpha1-antitrypsin. | 
| + | - | nl | Proc Am Thorac Soc 7(6):376-80 (2010) |
| 42 | 2010 | Lung disease associated with alpha1-antitrypsin deficiency. | 
| + | - | nl | Proc Am Thorac Soc 7(6):381-6 (2010) |
| 43 | 2004 | Alpha 1-antitrypsin: more than just deficiency. | 
| + | - | nl | Thorax 59(5):363-4 (2004) |
| 44 | 2006 | Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. | 
| + | - | nl | Thorax 61(6):485-90 (2006) |
| 45 | 2006 | The selective advantage of alpha1-antitrypsin deficiency. | 
| + | - | nl | Am J Respir Crit Care Med 173(10):1072-7 (2006) |
| 46 | 2004 | Alpha-1 antitrypsin deficiency with severe pulmonary emphysema. | 
| + | - | nl | Intern Med 43(3):223-6 (2004) |
| 47 | 2009 | Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. | 
| + | - | nl | Eur Respir J 34(2):475-88 (2009) |
| 48 | 2003 | Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. | 
| + | - | nl | Environ Health Perspect 111(16):1851-4 (2003) |